Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000146464 | SCV000193752 | pathogenic | Severe X-linked myotubular myopathy | 2013-02-08 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000146464 | SCV004196469 | pathogenic | Severe X-linked myotubular myopathy | 2023-10-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000146464 | SCV004298749 | pathogenic | Severe X-linked myotubular myopathy | 2023-07-17 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 158985). This variant is also known as ∆643–646 ACTT. This premature translational stop signal has been observed in individual(s) with X-linked myotubular myopathy (PMID: 9285787). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Tyr198Leufs*51) in the MTM1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MTM1 are known to be pathogenic (PMID: 9305655, 10063835). |